* The data is last updated on 10th February, 2023 from GISAID, based on 2379 variants from (14.9 million sequences) and 34 primer sets.
Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 2379 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2 (Omicron)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
AY.4.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
AY.100 (Delta)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
BA.1.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
B.1.525 (Eta)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
B.1.177.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
B.1.525 (Eta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
AY.4.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
BA.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
AY.100 (Delta)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
AY.100 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
B.1.525 (Eta)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
BA.1.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
B.1.177.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
B.1.1.7 (Alpha)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.2 (Omicron)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.1.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.1.13.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
B.1.1.7 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
AY.4.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
BA.1 (Omicron)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.1.15ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
B.1.177.7ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
BA.1 (Omicron)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
BA.2.12.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
BA.1 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
B.1.525 (Eta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
B.1.1.7 (Alpha)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
B.1.1.7 (Alpha)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-13463.1France
BA.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
B.1.177.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.1 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
AY.100 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.2 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
BA.2.12.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17571.6Singapore
BA.1.13.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
B.1.1.7 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
BA.2.12.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
BA.1 (Omicron)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
BA.2.12.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
BA.2.12.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
B.1.525 (Eta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
AY.4.2 (Delta)ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
BA.2 (Omicron)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
AY.4.2 (Delta)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
BA.1.15ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-15534.7France
BA.1.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19101.3US
BA.2 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
B.1.177.7ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-16534.9France
AY.100 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18904.7China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used